Graham joined Abingworth’s London office in January 2022 working with the transatlantic team in evaluating new investment opportunities and to support existing portfolio companies in a therapeutic area-agnostic approach. Previously, Graham spent time working with JJDC, the corporate investment arm of J&J, and Seroba Life Sciences, a pan-European VC. He also was Founder & Managing Director at healthcare-focused tech startup Techspert, where he built significant experience in scaling early stage ventures and navigating the challenges through development.
Graham holds a PhD in Medical Biology from the University of Cambridge, and a BA in Genetics from Trinity College Dublin.
